Advertisement

Topics

CP2D/AS-3 Blood Collection and Sampling System | Nutricel Additive System - CP2D [Medsep Corporation] | BioPortfolio

13:04 EST 27th January 2019 | BioPortfolio

Note: While we endeavour to keep our records up-to-date one should not rely on these details being accurate without first consulting a professional. Click here to read our full medical disclaimer.

CP2D/AS-3 Blood Collection and Sampling System with Nutricel Additive System

Instruction for Use for Systems Containing a Y Sampling Site (YSS) or Sample Diversion Pouch (with or without a pre-attached SampLok Vacuum Tube Holder).

Refer to unit foil package label for specific product description being used.

Sterile, nonpyrogenic fluid path. Sterilized by steam.

Rx only.

This product is free of natural rubber latex.

For collection of blood and preparation of red blood cells, plasma and platelets.

Failure to achieve and maintain a closed system during processing would result in a product that must be transfused within 24 hours.

Use aseptic technique. Use only if solutions are clear. If preparing a platelet concentrate, the platelet-rich plasma should be separated from the red blood cells within 8 hours after blood collection. If preparing fresh frozen plasma, separate from the red blood cells and place in the freezer at -18 °C or colder within 8 hours after collection.

* During processing, always observe the following precautions:

1. Sealing should be done in a manner that avoids fluid splatter.

2. Always dispose of blood-contaminated products in a manner consistent with established BIOHAZARD safety procedures.

Store CP2D/AS-3 preserved red blood cells at 1—6 °C for up to 42 days and use as indicated.

If AS-3 is not used, whole blood or red blood cells in CP2D alone may be stored at 1—6 °C for up to 21 days.

1. Load blood agitation device or suspend blood bag on donor scale and adjust donor scale to desired collection gross weight as per manufacturer's instructions.

2. Clamp donor tubing between DonorCare Needle Guard (DCNG) and Y Sampling Site.

3. Secure donor tubing above the Y connector and disinfect site of phlebotomy.

4. If using blood pressure cuff, inflate to not more than 60 mm Hg.

5. Remove donor needle cover and accomplish phlebotomy.

6. Release clamp and ensure there is blood flow. Reduce pressure as required.

7. Slide the DCNG midway over the needle hub and securely tape DCNG to the donor's arm as close to the top of the DCNG as possible. Note: If blood flow is slow, slide DCNG away from the needle hub, adjust and re-engage DCNG. If repeated needle adjustment is necessary, slide DCNG away from the needle hub and re-engage at the end of blood collection.

8. Collect appropriate volume of blood into collection bag, as indicated on packaging. Note: Mix blood and anticoagulant frequently during collection, for example, once every 45 seconds, and immediately after collection. If blood agitation device is used, follow manufacturer's operating instructions.

9. After required amount of blood has been collected, seal donor tubing close to Y Sampling Site.*

10. For blood sampling, remove the Y Sampling Site needle cover. Ensure the protective sheath is in place over the sampling needle.

11. Fasten the vacuum tube holder on to the base of the sampling needle.

12. Collect blood samples into vacuum tubes.

13. Ensure the vacuum tubes are centered within the vacuum tube holder during sample collection.

14. Maintain forward pressure on the vacuum tubes during sample collection. Note: After the last tube is collected, it is recommended that the vacuum tube holder be left in place.

15. After blood samples are collected, clamp donor tubing between the Y Sampling Site and DCNG, and as close to the DCNG as possible.

16. Release any remaining pressure from the donor's arm.

17. DCNG must be held stationary while the needle is withdrawn into it. While holding sides of DCNG near the front, grasp the tubing below the clamp and pull the needle into the DCNG until it locks into place, and the needle hub engages the bottom of the DCNG.

18. Insert the DCNG into the vacuum tube holder. Note: It is recommended that the DCNG be inserted securely into the vacuum tube holder, prior to discarding.

19. Seal donor tubing adjacent to DCNG.* Detach and discard needle, DCNG, Y Sampling Site and tubing.*

20. Strip tubing between seal and collection bag.

21. Continue to “Processing Instructions”, Step 1.

1. Load blood agitation device or suspend blood bag on donor scale and adjust donor scale to desired collection gross weight as per manufacturer's instructions.

2. Clamp donor tubing between DonorCare Needle Guard (DCNG) and Sampling Site.

3. Secure donor tubing above the Y connector and disinfect site of phlebotomy.

4. If using blood pressure cuff, inflate to not more than 60 mm Hg.

5. Remove donor needle cover and accomplish phlebotomy.

6. Release clamp and ensure there is blood flow.

7. Slide the DCNG midway over the needle hub and securely tape DCNG to the donor's arm as close to the top of the DCNG as possible. Note: If blood flow is slow, slide DCNG away from the needle hub, adjust and re-engage DCNG. If repeated needle adjustment is necessary, slide DCNG away from the needle hub and re-engage at the end of blood collection.

8. The donor blood will be automatically diverted to the sample diversion pouch. Once the sample diversion pouch is filled, close clamp immediately on tubing between the sample diversion pouch and Y connector. Warning: To avoid risk of air embolism to donor, do not squeeze sample diversion pouch while tubing is open.

9. Open snap-open closure between the Y connector and the collection bag to initiate blood collection. Reduce pressure as needed.

10. Permanently seal tubing between the sample diversion pouch and the Y connector to maintain sterility of the system prior to collecting blood samples.* Note: When using systems with a pre-attached SampLok vacuum tube holder, go to “When Using Systems with a Pre-attached SampLok Vacuum Tube Holder”.

11. For blood sampling, remove the Sampling Site needle cover. Ensure the protective sheath is in place over the sampling needle.

12. Fasten the vacuum tube holder on to the base of the sampling needle.

13. Position the sample diversion pouch downwards so that the air rises to the top of the pouch and away from the vacuum tube holder. Note: Drawing air into the vacuum tube may cause hemolysis.

14. Collect blood samples from the sample diversion pouch into vacuum tubes within approximately four minutes to avoid possible clot formation.

15. Ensure the vacuum tubes are centered within the vacuum tube holder during sample collection.

16. Maintain forward pressure on the vacuum tubes during sample collection. Note: After the last tube is collected, it is recommended that the vacuum tube holder be left in place.

17. Collect appropriate volume of blood into collection bag as indicated on packaging. Note: Mix blood and anticoagulant frequently during collection, for example, once every 45 seconds, and immediately after collection. If blood agitation device is used, follow manufacturer's operating instructions.

18. After required amount of blood has been collected, seal donor tubing close to snap-open closure.*

19. Clamp donor tubing between the Y connector and DCNG, as close as possible to the DCNG.

20. Release any remaining pressure from donor's arm.

21. DCNG must be held stationary while the needle is withdrawn into it. While holding sides of DCNG near the front, grasp the tubing below the clamp and pull the needle into the DCNG until it locks into place, and the needle hub engages the bottom of the DCNG.

22. Insert the DCNG into the vacuum tube holder, if desired. Note: It is recommended that the DCNG be inserted securely into the vacuum tube holder, prior to discarding.

23. Seal donor tubing adjacent to DCNG.* Detach and discard needle, DCNG, sample diversion pouch and tubing.*

24. Strip tubing between seal and collection bag.

25. Continue to “Processing Instructions”, Step 1.

1. To collect blood samples, open lid from SampLok vacuum tube holder.

2. Open snap-open closure between sample diversion pouch and SampLok vacuum tube holder.

3. Position the sample diversion pouch downwards so that the air rises to the top of the pouch and away from the SampLok vacuum tube holder. Note: Drawing air into the vacuum tube may cause hemolysis.

4. Collect blood samples from the sample diversion pouch into vacuum tubes within approximately four minutes to avoid possible clot formation.

5. Ensure the vacuum tubes are centered within the SampLok vacuum tube holder during sample collection.

6. Maintain forward pressure on the vacuum tubes during sample collection.

7. The lid may be closed on the SampLok vacuum tube holder after sample collection.

8. Return to “Blood Collection Instruction for Systems Containing a Sample Diversion Pouch with or without a Pre-attached SampLok Vacuum Tube Holder”, Step 17. Note: When collection of unit is complete, and the donor needle is engaged in the DCNG, open the lid of the SampLok vacuum tube holder and insert the DCNG into the holder. Twist until it locks into place. An audible click will confirm that it is locked.

1. Process whole blood within 72 hours of collection.

2. Mix whole blood/anticoagulant thoroughly.

3. Load whole blood and satellite bags into centrifuge cup, ensuring that the tubing stays in the top half of the cup.

4. Centrifuge at appropriate conditions to produce desired components.

5. Carefully remove the unit from the centrifuge and place the red cell storage bag in the plasma expressor.

6. Clamp tubing to extra satellite bags, if present.

7. Gently apply expressor pressure.

8. Open snap-open closure to satellite bag and express plasma.

9. After plasma is expressed, clamp tubing between red cell storage bag and Y connector, and release expressor pressure.

10. Clamp tubing between the Y connector and plasma bag.

11. Hang AS-3 bag above red cell storage bag and remove clamp from tubing to the red cell storage bag.

12. Open snap-open closure on the bag containing the AS-3 additive solution and transfer to the bag containing the red cells. Note: AS-3 solution should be added to the packed red blood cells immediately after removal of plasma. Transfer AS-3 solution under one of the following processing conditions:

a. within 8 hours of collection if whole blood is held at room temperature.

b. within 72 hours of collection if whole blood is refrigerated.

13. Seal tubing and detach the bag containing packed red cells, and set aside plasma for further processing.*

14. Gently mix packed red cells and AS-3 solution.

15. Store CP2D/AS-3 preserved red blood cells at 1—6 °C for up to 42 days and use as indicated. Note: If AS-3 is not used, whole blood or red blood cells in CP2D alone may be stored at 1—6 °C for up to 21 days.

Each shipping case contains 8 foil envelopes. Within each foil envelope resides 3 clear pouches containing an individual collection system. Each collection system consists of CP2D/AS-3 500 ml, Double Blood Bag Collection System with Nutricel Additive Solution and Sample Diversion Pouch.

CP2D 500 ANTICOAGULANT CITRATE PHOSPHATE DOUBLE DEXTROSE SOLUTION

AS-3 RED BLOOD CELLS, ADENINE - SALINE ADDED, 16.5 mEq sodium added.

From 500 ml CP2D Whole Blood. Store at 1—6 °C.

70 ml Anticoagulant Citrate Phosphate Double Dextrose Solution for collection of 500 ml of blood. Each 70 ml of CP2D solution contains 3.57 g dextrose (monohydrate), USP; 1.84 g sodium citrate (dihydrate), USP; 0.229 g citric acid (monohydrate), USP; and 0.155 g monobasic sodium phosphate (monohydrate), USP. Use only if solution is clear.

See circular of information for indications, contraindications, cautions and methods of infusion. VOLUNTEER DONOR. This product may transmit infectious agents. Rx only. PROPERLY IDENTIFY INTENDED RECIPIENT.

120-92

CP2D 500

See circular of information for indications, contraindications, cautions and methods of infusion. VOLUNTEER DONOR. This product may transmit infectious agents. Rx only. PROPERLY IDENTIFY INTENDED RECIPIENT.

120-92

AS-3 ADDITIVE SOLUTION

110 mL of preservative AS-3 contains: 1.21 g Dextrose (monohydrate), USP; 0.647 g Sodium Citrate (dihydrate), USP; 0.451 g Sodium Chloride, USP; 0.304 g Monobasic Sodium Phosphate (monohydrate), USP; 0.046 g Citric Acid (monohydrate), USP; 0.033 g Adenine. Contains 16.5 mEq of Sodium. Use only if solution is clear.

Do Not Store Any Blood Components In This Bag. Discard Bag After Using. See Direction Sheet.

14-3127-120

CP2D/AS-3 500 ml Double BLOOD COLLECTION SYSTEM with Nutricel Additive Solution with Sample Diversion Pouch

For collection of 500 ml of blood and preparation of red blood cells and plasma.

Each unit consists of a collection bag with 70 ml of CP2D solution, an additive bag with 110 ml of AS-3 solution, and one empty bag. Each 70 ml of CP2D solution contains 3.57 g dextrose (monohydrate), USP; 1.84 g sodium citrate (dihydrate), USP; 0.229 g citric acid (monohydrate), USP; and 0.155 g monobasic sodium phosphate (monohydrate), USP. Each 110 ml of AS-3 solution contains 1.21 g dextrose (monohydrate), USP; 0.647 g sodium citrate (dihydrate), USP; 0.451 g sodium chloride, USP; 0.304 g monobasic sodium phosphate (monohydrate), USP; 0.046 g citric acid (monohydrate), USP; and 0.033 g adenine, USP.

Sterile, nonpyrogenic fluid path. Sterilized by steam. See accompanying directions for use. Rx only. Store at room temperature. Unused bags in opened pouches may be kept 30 days by folding and SECURING open end of pouch to prevent possible loss of moisture.

120-92

Pall and Nutricel are registered trademarks of Pall Corporation. Redefining the Business of Blood is a service mark of Pall Corporation. DonorCare and SampLok are registered trademarks of ITL Corporation, Canberra, Australia.

Medsep Corporation, A Subsidiary of Pall Corp., Covina, CA 91722, USA

Visit us at www.pall.com/medical

For Pall customer service, call: 1.800.645.6578

Manufacturer

Medsep Corporation

Active Ingredients

Source

Drugs and Medications [8 Associated Drugs and Medications listed on BioPortfolio]

Rejuvesol [citra labs llc]

rejuvesol red blood cell processing solution

Nutricel additive system - cp2d [haemonetics manufacturing inc]

CP2D/AS-3 Blood Collection and Sampling System

Nutricel additive solution - cp2d [haemonetics manufacturing inc.]

CP2D/AS-3 Blood Collection and Sampling System

Nutricel additive solution - cp2d [haemonetics manufacturing inc.]

CP2D/AS-3 Blood Collection and Sampling System

Haemonetics additive solution formula 3 (as-3) [haemonetics corporation]

Haemonetics Additive Solution Formula 3 (AS-3)

Clinical Trials [3461 Associated Clinical Trials listed on BioPortfolio]

Evaluation of Questionnaires of Tumor Patients With and Without Additive Homeopathic Therapy

Tumor patients receiving conventional tumor therapies may choose to receive additional homeopathic therapy. The patients are randomized into two groups receiving either additive homeopathi...

Evaluation of Additive Manufacture in the Production of Orthotic Insoles

This study will assess the ability of different orthotic insole treatments to reduce pressure under the ball of the foot. This is important for people who have diabetes because their feet ...

Additive Effects of Pravastatin and Valsartan

The investigators hypothesize that pravastatin combined with valsartan may have additive effects in hypertensive, hypercholesterolemic patients.

Clinical Study to Assess the Performance of the Dialyzer With Endexo™

EndexoTM is an additive that is blended into the fiber solution during manufacturing of the hemodialyzer hollow fibers. The intended purpose of the additive is to increase blood compatibil...

In Vivo Recovery and Survival Study of Platelets Collected on Trima Accel System and Stored in InterSol Solution

The purpose of this study is to evaluate the quality of platelets collected on the Trima Accel system after storage for 5 days in a Platelet Additive Solution (PAS), called InterSol.

PubMed Articles [8726 Associated PubMed Articles listed on BioPortfolio]

To STABILISE or not: Is the additive time of additive benefit?

Preparing coal slurry from coking wastewater to achieve resource utilization: Slurrying mechanism of coking wastewater-coal slurry.

Coking wastewater is used to prepare coal slurry, which can be used as combustion and gasification fuel. This promising technology simultaneously achieves resource utilization and wastewater managemen...

Estimation of additive and non-additive genetic variances of body weight in crossbreed populations of the Japanese quail.

A major part of the growth performance in birds is the result of the combined effects of genes, including the general and specific combining ability that requires the design of an optimal mating syste...

Questioning the long-term stability of the additive model in comorbid CTD+ADHD - The transition from childhood to adulthood.

A previous study (Roessner et al. 2007) found psychopathological evidence of an additive model of the comorbid group with Chronic Tic Disorders and Attention Deficit Hyperactivity Disorder (CTD+ADHD),...

In situ synthesis of tin dioxide submicrorods anchored on nickel foam as an additive-free anode for high performance sodium-ion batteries.

A hybrid of tin dioxide submicrorods anchored on conductive nickel foam (SnO submicrorods-Ni foam) is in-situ synthesized via a hydrothermal and a subsequent heat treatment by using stannic chloride a...

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Blood
Blood is a specialized bodily fluid that delivers necessary substances to the body's cells (in animals) – such as nutrients and oxygen – and transports waste products away from those same cells.  In vertebrates, it is composed of blo...

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...


Drugs and Medication Quicklinks


Searches Linking to this Drug Record